The first Ionis Pharmaceuticals trade was made in Q4 2015.
Since then Baillie Gifford bought shares eleven more times and sold shares on 25 occasions. The investor completely sold their stake between Q1 2023 and Q4 2024.
Avg closing price
Price range
Sold -39.6 Thousand shares
Q4 2024
Avg closing price
$37.31
Price range
$33.73
-
$40.36
Sold 84.8% shares (-221 Thousand shares)
Q3 2024
Avg closing price
$46.53
Price range
$40.06
-
$51.86
Sold 12.0% shares (-35.4 Thousand shares)
Q2 2024
Avg closing price
$41.01
Price range
$36.45
-
$47.70
Sold 0.9% shares (-2.8 Thousand shares)
Q1 2024
Avg closing price
$47.67
Price range
$42.03
-
$53.55
Sold 5.7% shares (-18.1 Thousand shares)
Q4 2023
Avg closing price
$47.90
Price range
$43.39
-
$51.63
Sold 4.2% shares (-13.7 Thousand shares)
Q3 2023
Avg closing price
$41.26
Price range
$38.50
-
$47.13
Sold 0.7% shares (-2.31 Thousand shares)
Q2 2023
Avg closing price
$38.43
Price range
$34.73
-
$43.33
Sold 0.3% shares (-1.13 Thousand shares)
Q1 2023
Avg closing price
$37.55
Price range
$33.58
-
$41.20
Increased shares by 2.8% (+8.95 Thousand shares)
Q4 2022
Avg closing price
$42.06
Price range
$37.12
-
$46.52
Increased shares by 4.4% (+13.8 Thousand shares)
Q3 2022
Avg closing price
$42.14
Price range
$36.54
-
$48.66
Sold 10.8% shares (-37.8 Thousand shares)
Q2 2022
Avg closing price
$37.71
Price range
$31.71
-
$43.00
Increased shares by 10.5% (+33 Thousand shares)
Q1 2022
Avg closing price
$32.73
Price range
$29.88
-
$37.04
Increased shares by 4.6% (+13.8 Thousand shares)
Q4 2021
Avg closing price
$31.48
Price range
$25.61
-
$35.10
Increased shares by 11.3% (+30.6 Thousand shares)
Q3 2021
Avg closing price
$37.68
Price range
$33.54
-
$40.55
Increased shares by 14.1% (+33.4 Thousand shares)
Q2 2021
Avg closing price
$39.17
Price range
$34.54
-
$47.25
Increased shares by 88.5% (+112 Thousand shares)
Q1 2021